MetaboloStasis Therapeutics

601 Genome Way Northwest, Huntsville, Alabama 35806
601 Genome Way Northwest Huntsville Alabama 35806 US

Contact Name
Tracy Nevitt

MetaboloStasis Therapeutics is dedicated to developing novel therapeutics for the treatment of human metabolic and proinflammatory disorders. The company is primarily focused on two human conditions, diabetes mellitus type 2 and Menkes Disease, an X-linked fatal childhood disorder of systemic copper deficiency. These diseases have vastly contrasting rates of incidence, with the former currently reaching pandemic levels in the USA and the latter a rare or orphan disease with an incidence of 1 in 250,000-350,000 live births.